<html>
<head>PUBMED IDs for CXXC5</head>
<body bgcolor='#C5F0F2'><h1>CXXC5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15375572/'>Identification and characterization of human CXXC10 gene in silico.</a> September 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15547684/'>Identification and characterization of FBXL19 gene in silico.</a> November 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/19182210/'>Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.</a> May 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19388938/'>Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.</a> September 11  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20220130/'>A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.</a> June 12  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21325450/'>RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.</a> December 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22544055/'>Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.</a> January 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22626544/'>Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.</a> October 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23190153/'>Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.</a> April 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23303788/'>Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2.</a> May 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23988457/'>CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.</a> July 11  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25433557/'>CXXC5 regulates differentiation of C2C12 myoblasts into myocytes.</a> July 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25605239/'>Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25805812/'>Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.</a> July 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25805808/'>Loss-of-function de novo mutations play an important role in severe human neural tube defects.</a> March 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25805801/'>Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.</a> May 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25805798/'>Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.</a> May 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26436701/'>Length of paternal lifespan is manifested in the DNA methylome of their nonagenarian progeny.</a> August 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28067315/'>KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors.</a> January 10  2017<br></body></html>
